セリアック病の小児における疾患関連知識の評価のためのツールの開発と検証
Sophie Hall1,2, Kristin Kenrick3, Kirsten J Coppell4
1Department of Paediatrics and Child Health, University of Otago Christchurch, 4 Oxford Terrace, Christchurch 8011, New Zealand.
Journal of clinical medicine
|February 13, 2026
まとめ
CD-Knowという新しいツールが開発され,小児のセリアック病 (CD) 知識の評価に有効化されました. このツールは,知識のギャップを特定し,小児CDの自己管理のための介入を評価するのに役立ちます.
科学分野:
- 小児の胃腸内科について
- 保健教育 保健教育について
- 病気管理 病気管理
背景:
- セリアック病 (CD) の小児における疾患特有の知識の評価は,効果的な自己管理に不可欠です.
- CDの小児集団に合わせた検証された知識評価ツールが欠けていました.
研究 の 目的:
- 疾患特有の知識評価ツール (CD-Know) を開発・検証し,CDを患っている子ども向けに活用する.
- このツールは,小児性セリアック病に関する知識の評価に適していることを保証します.
主な方法:
- 初期項目を開発するために,文献と専門家のレビューのコンテンツ合成.
- パイロットテスト,検証研究,アイテムレスポンス分析の複数のラウンドで,多様な参加者グループが関与しています.
- 単変数線形モデル,信頼性 (テスト・再テスト,内部一致性),および相関分析を含む統計分析.
主要な成果:
- 15項目のCD-Knowツールは,グループ (CDの子供,同居者,医療従事者,一般の人々) 間で明確な知識の階層を示した.
- CDの子どもは,同居者と医療従事者よりも低いスコアを得ましたが,CDのない子供よりも高いスコアを得ました.
- CD-Knowスコアは,CDの小児におけるグルテンフリーダイエット遵守と正の相関関係を示した (R=0.30,p=0.017).
- このツールは良好なテスト再テスト信頼性 (ICC=0.73) と内部一貫性 (Cronbach's alpha=0.71) を示した.
結論:
- CD-Knowは,セリアック病と診断された小児の疾患関連の知識を評価するための検証済みのツールです.
- このツールは,小児CD患者の知識改善が必要な領域を特定するために利用できます.
- CD-Knowは,CDに関する知識を高めるための介入の効果を評価するための手段を提供します.
関連する概念動画
Inflammatory Bowel Disease II: Crohn's Disease
1.2K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Immunodeficiency Diseases
2.5K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.5K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
210
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
210
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.2K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.2K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
981
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
981


